Pharma Investments, Ventures & Law Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Pharma Investments, Ventures & Law Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Eclipsys Corporation
Eclipsys Announces Fourth-Quarter and Year-End 2008 Results
March 15th, 2009
Eclipsys Corporation® (NASDAQ: ECLP), The Outcomes Company®, announced results for the fourth quarter and year ended December 31, 2008. Revenues Revenues for the quarter ended December 31, 2008 were $126.8 million, compared to revenues of $124.4 million for the quarter ended December 31, 2007. Revenues for the year ended 2008 were $515.8 million, compared to $477.5 million for the year ended 2007. GAAP Net Income On a GAAP basis, net income for the fourth quarter of 2008 was $3.3 million, or $0.06 per diluted common share, compared to net income of $24.2 million, or $0.44 per diluted common share in the fourth quarter of 2007. GAAP net income for the year ended December 31, 2008 was $99.5...
Source: Pharma Investments, Ventures & Law Weekly (2009-03-15)
|
